Paper3606944
Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours.
Milano G and 9 others. Br J Cancer, 1987. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours. Papers, record 3606944. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3606944
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Tamoxifen | Major topic |
| Chromatography, High Pressure Liquid | |
| Cytosol | |
| Female | |
| Humans | |
| Methods |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6542011 | Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare. | Eur J Cancer Clin Oncol | 1984 | https://conductscience.org/library/papers/6542011 | PubMed |
| 2 | 6488162 | Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. | Cancer Res | 1984 | https://conductscience.org/library/papers/6488162 | PubMed |
| 3 | 3978620 | Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. | Cancer Res | 1985 | https://conductscience.org/library/papers/3978620 | PubMed |
| 4 | 4015045 | Antiestrogen binding sites in human breast cancer biopsies. Measurement ligand-specificity and affinity, and correlation to estrogen and progesterone receptors. | Anticancer Res | 1985 | https://conductscience.org/library/papers/4015045 | PubMed |
| 5 | 7364914 | Paired-ion chromatographic analysis of tamoxifen and two major metabolites in plasma. | J Chromatogr | 1980 | https://conductscience.org/library/papers/7364914 | PubMed |
| 6 | 7427960 | Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers. | Cancer Treat Rep | 1980 | https://conductscience.org/library/papers/7427960 | PubMed |
| 7 | 7427961 | Clinical pharmacology of tamoxifen in patients with breast cancer: comparison of traditional and loading dose schedules. | Cancer Treat Rep | 1980 | https://conductscience.org/library/papers/7427961 | PubMed |
| 8 | 7471314 | Clinical pharmacology of tamoxifen and N-desmethyltamoxifen in patients with advanced breast cancer. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7471314 | PubMed |
| 9 | 7227442 | The binding of tamoxifen to human mammary carcinoma cytosol. | Eur J Cancer (1965) | 1980 | https://conductscience.org/library/papers/7227442 | PubMed |
| 10 | 7317574 | Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: correlation with blood levels in patients with metastatic breast cancer. | Biopharm Drug Dispos | 1981 | https://conductscience.org/library/papers/7317574 | PubMed |
| 11 | 7199465 | Determination of tamoxifen and biologically active metabolites in human breast tumours and plasma. | Eur J Cancer Clin Oncol | 1981 | https://conductscience.org/library/papers/7199465 | PubMed |
| 12 | 6848356 | Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat. | Endocrinology | 1983 | https://conductscience.org/library/papers/6848356 | PubMed |
| 13 | 6870933 | Identification and biological activity of tamoxifen metabolites in human serum. | Biochem Pharmacol | 1983 | https://conductscience.org/library/papers/6870933 | PubMed |
| 14 | 6883318 | Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. | Cancer Res | 1983 | https://conductscience.org/library/papers/6883318 | PubMed |
| 15 | 6619251 | High-performance liquid chromatographic analysis of tamoxifen and major metabolites in human plasma. | J Chromatogr | 1983 | https://conductscience.org/library/papers/6619251 | PubMed |
| 16 | 6626456 | Simultaneous micro measurement of steroid receptors in breast cancer. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6626456 | PubMed |
| 17 | 6685632 | A comparative study of electrophoretic mobilities of [3H]-estradiol and monohydroxytamoxifen binding components in the cytosols of human breast carcinomas and sera of healthy adult females. | Eur J Cancer Clin Oncol | 1983 | https://conductscience.org/library/papers/6685632 | PubMed |
| 18 | 6692388 | Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor. | Cancer Res | 1984 | https://conductscience.org/library/papers/6692388 | PubMed |
| 19 | 6362856 | Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration. | Cancer Res | 1984 | https://conductscience.org/library/papers/6362856 | PubMed |
| 20 | 6420159 | The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumours. | Eur J Cancer Clin Oncol | 1984 | https://conductscience.org/library/papers/6420159 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 17526937 | Tamoxifen activates CYP3A4 and MDR1 genes through steroid and xenobiotic receptor in breast cancer cells. | Endocrine | 2006 | https://conductscience.org/library/papers/17526937 | PubMed |
| 15587933 | Potential beneficial metabolic interactions between tamoxifen and isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes. | Pharm Res | 2004 | https://conductscience.org/library/papers/15587933 | PubMed |
| 3048447 | The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole. | Breast Cancer Res Treat | 1988 | https://conductscience.org/library/papers/3048447 | PubMed |
| 2803912 | Tamoxifen metabolism: pharmacokinetic and in vitro study. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2803912 | PubMed |
| 2736207 | Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2736207 | PubMed |
| 2661195 | Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. | Drugs | 1989 | https://conductscience.org/library/papers/2661195 | PubMed |
| 1505141 | Clinical pharmacokinetics of endocrine agents used in advanced breast cancer. | Clin Pharmacokinet | 1992 | https://conductscience.org/library/papers/1505141 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3606944
GET https://conductscience.org/api/papers/v1/3606944/references?page=2